Compass Pathways Cheers Trump Order To Accelerate Access To Psychedlic Drug Treatements: ‘Recognizes Profound Urgency Of Mental Health Crisis’

All NewsApril 19, 2026

Compass Pathways said a White House executive order may speed FDA review of its psilocybin therapy COMP360 for treatment-resistant depression trials.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent